Suga S - Search Results

1

The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

Katsuta T, Shimizu N, Okada K, Tanaka-Taya K, Nakano T, Kamiya H, Amo K, Ishiwada N, Iwata S, Oshiro M, Okabe N, Kira R, Korematsu S, Suga S, Tsugawa T, Nishimura N, Hishiki H, Fujioka M, Hosoya M, Mizuno Y, Mine M, Miyairi I, Miyazaki C, Morioka I, Morishima T, Yoshikawa T, Wada T, Azuma H, Kusuhara K, Ouchi K, Saitoh A, Moriuchi H. Katsuta T, et al. Among authors: suga s. Pediatr Int. 2022 Jan;64(1):e14912. doi: 10.1111/ped.14912. Epub 2021 Nov 10. Pediatr Int. 2022. PMID: 34233075 Free PMC article.

2

Moyamoya disease associated with bilateral renal artery stenosis.

Nakano T, Azuma E, Ido M, Itoh M, Sakurai M, Suga S, Kawaguchi H. Nakano T, et al. Among authors: suga s. Acta Paediatr Jpn. 1993 Aug;35(4):354-7. doi: 10.1111/j.1442-200x.1993.tb03070.x. Acta Paediatr Jpn. 1993. PMID: 8379330 Review.

3

Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease.

Tamura K, Matsubara K, Ishiwada N, Nishi J, Ohnishi H, Suga S, Ihara T, Chang B, Akeda Y, Oishi K; Japanese IPD Study Group. Tamura K, et al. Among authors: suga s. Vaccine. 2014 Mar 14;32(13):1444-50. doi: 10.1016/j.vaccine.2014.01.031. Epub 2014 Jan 29. Vaccine. 2014. PMID: 24486367

4

Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.

Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, Saitoh A, Oishi T, Hosoya M, Togashi T, Oishi K, Ihara T. Suga S, et al. Vaccine. 2015 Nov 9;33(45):6054-60. doi: 10.1016/j.vaccine.2015.07.069. Epub 2015 Jul 31. Vaccine. 2015. PMID: 26235372

5

Symposium report of the 17th annual meeting of the Japanese Society for Vaccinology, 2013: Bacterial vaccines: Effectiveness and issues.

Nakano T, Watanabe M, Saitoh A, Suga S, Oishi K, Nishimura N. Nakano T, et al. Among authors: suga s. Vaccine. 2016 Apr 7;34(16):1956-7. doi: 10.1016/j.vaccine.2015.09.084. Epub 2015 Oct 1. Vaccine. 2016. PMID: 26431988 No abstract available.

6

Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan.

Asada K, Kamiya H, Suga S, Nagao M, Ichimi R, Fujisawa T, Umemoto M, Tanaka T, Ito H, Tanaka S, Ido M, Taniguchi K, Ihara T, Nakano T. Asada K, et al. Among authors: suga s. Western Pac Surveill Response J. 2016 Nov 14;7(4):28-36. doi: 10.5365/WPSAR.2016.7.3.005. eCollection 2016 Oct-Dec. Western Pac Surveill Response J. 2016. PMID: 28246579 Free PMC article.

7

Changes in Rotavirus Genotypes before and after Vaccine Introduction: a Multicenter, Prospective Observational Study in Three Areas of Japan.

Tanaka T, Kamiya H, Asada K, Suga S, Ido M, Umemoto M, Ouchi K, Ito H, Kuroki H, Nakano T, Taniguchi K. Tanaka T, et al. Among authors: suga s. Jpn J Infect Dis. 2017 Jul 24;70(4):448-452. doi: 10.7883/yoken.JJID.2016.286. Epub 2017 Feb 28. Jpn J Infect Dis. 2017. PMID: 28250254 Free article.

8

Characterization of unusual DS-1-like G3P[8] rotavirus strains in children with diarrhea in Japan.

Komoto S, Ide T, Negoro M, Tanaka T, Asada K, Umemoto M, Kuroki H, Ito H, Tanaka S, Ito M, Fukuda S, Suga S, Kamiya H, Nakano T, Taniguchi K. Komoto S, et al. Among authors: suga s. J Med Virol. 2018 May;90(5):890-898. doi: 10.1002/jmv.25016. Epub 2018 Feb 5. J Med Virol. 2018. PMID: 29315643

9

A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.

Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, Fujieda M, Oda M, Asada K, Nakano T, Saitoh A, Hosoya M, Togashi T, Matsuoka M, Kimura K, Shibayama K. Suga S, et al. Vaccine. 2018 Sep 11;36(38):5678-5684. doi: 10.1016/j.vaccine.2018.08.029. Epub 2018 Aug 16. Vaccine. 2018. PMID: 30122645

10

Persistence of Antibodies against Diphtheria, Tetanus, Pertussis, and Poliovirus Types I, II, and III Following Immunization with DTaP Combined with Inactivated Wild-Type Polio Vaccine (DTaP-wIPV).

Nakayama T, Suga S, Okada K, Okabe N. Nakayama T, et al. Among authors: suga s. Jpn J Infect Dis. 2019 Jan 23;72(1):49-52. doi: 10.7883/yoken.JJID.2018.314. Epub 2018 Oct 31. Jpn J Infect Dis. 2019. PMID: 30381690 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page